The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
G‐protein‐coupled receptor for short‐chain fatty acids suppresses colon cancer
Abstract
GPR43 is a G‐protein‐coupled receptor for short‐chain fatty acids (SCFAs). Expression of GPR43 is detected in hematopoietic tissues and the large intestine. SCFAs are derived from bacterial fermentation and metabolism of undigested dietary fibers and have been recognized for their cancer prevention activities in the colon. The role of SCFAs, particularly butyrate, in colon cancer therapy has been extensively studied, and its tumor suppressive functions are believed to be due to their intracellular actions, notably inhibition of histone deacetylase. In our study, we show that SCFAs also exert their antitumor effects via receptor GPR43 and that GPR43 is frequently lost in colon cancer cells. Immunohistostaining revealed that GPR43 immunoreactivity was high in normal colon tissues ( N = 31) but was markedly reduced or completely lost in most colorectal adenocarcinoma tissues ( N = 70) and their corresponding lymph node metastatic adenocarcinomas ( N = 38). RT‐PCR analysis detected the presence of full length GPR43 mRNA in only one (HT‐29) of nine established human colon cancer cell lines. Restoration of GPR43 expression in HCT8 human colonic adenocarcinoma cells induced G0/G1 cell cycle arrest and activated caspases, leading to increased apoptotic cell death after propionate/butyrate treatment. Restored GPR43 expression, coupled with propionate treatment, induced an upregulation of p21 and a decrease in the levels of cyclin D3 and cyclin‐dependent kinases (CDKs) 1 and 2, while the CDK4 and CDK6 levels remained unchanged. Our results suggest that GPR43 functions as a tumor suppressor by mediating SCFA‐induced cell proliferation inhibition and apoptotic cell death in colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 1×
“p15 and p16 have been shown to be able to specifically inhibit cyclin D/CDK4/6 complexes.(43,44) As shown in Figure 5b, in contrast to the significant downregulation of CDK1/2, we observed only slight changes of CDK4/6 during GPR43/ propionate treatment.”
ResultShort chain fatty acids in human large intestine, portal, hepatic and venous blood
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P., & Macfarlane, G. T. (1987) · Gut · doi:10.1136/gut.28.10.1221 · Cited by 3,119
Brown, A. J., Goldsworthy, S. M., Barnes, A. A., Eilert, M. M., Tcheang, L., Daniels, D., Muir, A. I., Wigglesworth, M. J., Kinghorn, I., Fraser, N. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211609200 · Cited by 2,409
The Role of DNA Methylation in Mammalian Epigenetics
Jones, P. A., & Takai, D. (2001) · Science · doi:10.1126/science.1063852 · Cited by 2,070
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Le Poul, E., Loison, C., Struyf, S., Springael, J.-Y., Lannoy, V., Decobecq, M.-E., Brezillon, S., Dupriez, V., Vassart, G., Van Damme, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301403200 · Cited by 1,651
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“It may also enhance assembly and activity in complexes of CDK4 or CDK6 and cyclin D.(39) The carboxy-terminal region of p21 is sufficient to bind and inhibit PCNA, a subunit of DNA polymerase, and may coordinate DNA replication with cell cycle progression.”
Backgroundp53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Xiong, Y., Miyamoto, N., Shibata, K., Valasek, M. A., Motoike, T., Kedzierski, R. M., & Yanagisawa, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2637002100 · Cited by 731
The histone H4 acetyltransferase MOF uses a C 2 HC zinc finger for substrate recognition
Akhtar, A., & Becker, P. B. (2001) · EMBO reports · doi:10.1093/embo-reports/kve022 · Cited by 632
Review article: short chain fatty acids in health and disease
Cook, & Sellin (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00337.x · Cited by 619
Trock, B., Lanza, E., & Greenwald, P. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.8.650 · Cited by 555
Nilsson, N. E., Kotarsky, K., Owman, C., & Olde, B. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00488-1 · Cited by 540
Karaki, S.-I., Mitsui, R., Hayashi, H., Kato, I., Sugiya, H., Iwanaga, T., Furness, J. B., & Kuwahara, A. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0140-x · Cited by 460
Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O'Donnell, M., & Hurwitz, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.18.8655 · Cited by 416
Hague, A., Elder, D. J. E., Hicks, D. J., & Paraskeva, C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600322 · Cited by 412
Jan, G., Belzacq, A.-S., Haouzi, D., Rouault, A., Métivier, D., Kroemer, G., & Brenner, C. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400935 · Cited by 385 · cited 1×
“Propionate was also shown to inhibit cell growth and trigger apoptosis in other colorectal carcinoma cells.(15,16) The data suggest that SCFAs guard against colon carcinogenesis.”
BackgroundMedina, V., Edmonds, B., Young, G. P., James, R., Appleton, S., & Zalewski, P. D. (1997) · PubMed · Cited by 377
Pestell, R. G., Albanese, C., Reutens, A. T., Segall, J. E., Lee, R. J., & Arnold, A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0373 · Cited by 375
Heerdt, B. G., Houston, M. A., & Augenlicht, L. H. (1994) · PubMed · Cited by 360
Expression of the short-chain fatty acid receptor, GPR43, in the human colon
Karaki, S.-I., Tazoe, H., Hayashi, H., Kashiwabara, H., Tooyama, K., Suzuki, Y., & Kuwahara, A. (2008) · Journal of Molecular Histology · doi:10.1007/s10735-007-9145-y · Cited by 336
Willett, W. C. (2000) · The Oncologist · doi:10.1634/theoncologist.5-5-393 · Cited by 243
Kim, Y. S., Tsao, D., Siddiqui, B., Whitehead, J. S., Arnstein, P., Bennett, J., & Hicks, J. (1980) · Cancer · doi:10.1002/1097-0142(19800315)45:5+<1185::aid-cncr2820451324>3.0.co;2-w · Cited by 234
Gamet, L., Daviaud, D., Denis‐Pouxviel, C., Remesy, C., & Murat, J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520222 · Cited by 195
Inhibitors of the Cip/Kip Family
Hengst, L., & Reed, S. I. (1998) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-71941-7_2 · Cited by 158
Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer
Chen, Y., Tang, Y., Wang, M.-T., Zeng, S., & Nie, D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4758 · Cited by 143
Self-citationLeu, R. K. L., Brown, I. L., Hu, Y., Morita, T., Esterman, A., & Young, G. P. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl245 · Cited by 138
Tang, S., Bhatia, B., Maldonado, C. J., Yang, P., Newman, R. A., Liu, J., Chandra, D., Traag, J., Klein, R. D., Fischer, S. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111936200 · Cited by 122
Ruemmele, F. M., Dionne, S., Qureshi, I. A., Sarma, D. S. R., Levy, E. H., & Seidman, E. G. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400545 · Cited by 110
Time of day and glucose tolerance status affect serum short-chain fatty concentrations in humans
Wolever, T. M. S., Josse, R. G., Leiter, L. A., & Chiasson, J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90127-x · Cited by 105
Wang, J., Yang, L., Yang, J., Kuropatwinski, K. K., Wang, W., Liu, X.-Q., Hauser, J., & Brattain, M. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5348 · Cited by 98
LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3
Senga, T., Iwamoto, S., Yoshida, T., Yokota, T., Adachi, K., Azuma, E., Hamaguchi, M., & Iwamoto, T. (2003) · Blood · doi:10.1182/blood-2002-06-1881 · Cited by 86
SCFAs: The Enigma of Weak Electrolyte Transport in the Colon
Sellin, J. H. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.2.58 · Cited by 73
Short-chain fatty acid absorption in rabbit colon in vitro
Sellin, J. H., & DeSoignie, R. C. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)90954-y · Cited by 65
Short-chain fatty acid modulation of apoptosis in the kato III human gastric carcinoma cell line
Matthews, G. M., Howarth, G. S., & Butler, R. N. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.7.4318 · Cited by 60
Chen, D., Li, X., Zhai, Z., & Shu, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108675200 · Cited by 59
Resistant Starch and Colorectal Neoplasia
Young, G. P., & Leu, R. K. L. (2004) · Journal of AOAC International · doi:10.1093/jaoac/87.3.775 · Cited by 47
Short-chain fatty acid modulation of apoptosis in gastric and colon cancer cells.
Matthews, G. M. (2007) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · Cited by 3
Cited by
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r036012 · Cited by 5,048
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Lloyd-Price, J., Abu-Ali, G., & Huttenhower, C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0307-y · Cited by 1,891
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Metadata
- Authors
- Tang, Y., Chen, Y., Jiang, H., Robbins, G. T., & Nie, D.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-10-26
- Volume
- 128
- Issue
- 4
- Pages
- 847-856
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2023113611
- Cited by
- 281
- References
- 45
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.